2025-05-02 09:23:55
Latest Post
Godrej Agrovet Limited consolidated Q4FY25 net profit drops QoQ to Rs. 70.78 crores
L G Balakrishnan & Bros Ltd posts Rs. 84.03 crores consolidated profit in Q4FY25
Swastika Investmart Ltd Q4 FY2025 consolidated profit slumps to Rs. 27.17 lakhs
Vertex Securities Ltd consolidated Q4 FY25 loss at Rs. 53.99 lakhs
The Federal Bank Limited consolidated Q4FY25 PAT jumps to Rs. 1108.31 crores
Stock Report
Biofil Chemicals and Pharmaceuticals Q3 FY2021-22 net profit up QoQ at Rs. 34.04 lakhs
Posted On : 2022-02-16 20:13:57( TIMEZONE : IST )
Biofil Chemicals & Pharmaceuticals Limited has reported Standalone financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 1.6987 crores during the period ended December 31, 2021 as compared to Rs. 13.7690 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. 0.3404 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 0.2126 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. 0.21 for the period ended December 31, 2021 as compared to Rs. 0.13 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹ 1.6987 crs | ₹13.7690 crs |  -87.66% |
| Net Profit | ₹0.3404 crs | ₹0.2126 crs |  60.11% |
| EPS | ₹0.21 | ₹0.13 | 61.54% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs. 1.6987 crores during the period ended December 31, 2021 as compared to Rs.3.2142 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.0.3404 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.0.5125 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.0.21 for the period ended December 31, 2021 as compared to Rs.0.31 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹ 1.6987 crs | ₹3.2142 crs | -47.15% |
| Net Profit | ₹0.3404 crs | ₹0.5125 crs | -33.58% |
| EPS | ₹0.21 | ₹0.31 | -32.26% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.20.8570 crores during the 9 Months period ended December 31, 2021 as compared to Rs.22.3159 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.0.7270 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.1.6563 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.0.45 for the 9 Months period ended December 31, 2021 as compared to Rs.1.02 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹20.8570 crs | ₹22.3159 crs | -6.54% |
| Net Profit | ₹0.7270 crs | ₹1.6563 crs | -56.11% |
| EPS | ₹0.45 | ₹1.02 | -55.88% |
Shares of Biofil Chemicals & Pharmaceuticals Limited was last trading in BSE at Rs. 72.60 as compared to the previous close of Rs. 66.00. The total number of shares traded during the day was 8700 in over 232 trades.
The stock hit an intraday high of Rs. 72.60 and intraday low of 66.70. The net turnover during the day was Rs. 613935.00.
